A self control study on the effect of Vonoprazan on intestinal flora in patients with indications

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100047119

Enrollment

Unknown

Registered

2021-06-08

Start date

2021-06-01

Completion date

Unknown

Last updated

2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammatory bowel disease

Interventions

Experimental group:Vonoprazan

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with gastritis, reflux esophagitis and other indications.

Exclusion criteria

Exclusion criteria: Long-term or recent use of any other medication.

Design outcomes

Primary

Measure	Time frame
intestinal flora;reflux heartburn and other symptoms relieved;	—

Countries

China

Contacts

Public ContactLiu Zhanju

The Shanghai Tenth People'e Hospital

liuzhanju88@126.com+86 21 6630 1174

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026